Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection

F. Ansaldi, B. Bruzzone, G. Testino, M. Bassetti, R. Gasparini, P. Crovari, G. Icardi

Research output: Contribution to journalArticle

Abstract

Reduction of the window period of hepatitis C virus (HCV) infection represents an important goal in the transfusional and diagnostic setting. A prototype assay designed to simultaneously detect circulating HCV antigen and anti-HCV, has been developed. Aim of this study was to evaluate the performance of this new assay in terms of specificity and sensitivity and to compare its efficacy with commercial assays. To evaluate the specificity of the assay, 400 samples from the general population and 100 'difficult' sera, negative for anti-HCV, were tested. To assess sensitivity, the new test was used on 76 PCR-positive and anti-HCV negative sera, seven natural or commercial seroconversion panels that included 17 RNA-positive and anti-HCV negative sera and 31 anti-HCV positive sera, 20 weak anti-HCV positive sera, 80 viraemic and anti-HCV-positive sera from patients infected with different subtypes and 10 sera from patients with HBV-HCV or HIV-HCV co-infections. Of 500 anti-HCV negative samples, 499 (99.8%) were negative with a cut-off index

Original languageEnglish
Pages (from-to)5-10
Number of pages6
JournalJournal of Viral Hepatitis
Volume13
Issue number1
DOIs
Publication statusPublished - Jan 2006

Fingerprint

Hepatitis C Antigens
Hepatitis C Antibodies
Immunoassay
Hepacivirus
Early Diagnosis
Infection
Serum
Virus Diseases
Coinfection

Keywords

  • Antigen
  • Diagnosis
  • HCV
  • Immunoassay
  • Window period

ASJC Scopus subject areas

  • Hepatology
  • Virology

Cite this

Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection. / Ansaldi, F.; Bruzzone, B.; Testino, G.; Bassetti, M.; Gasparini, R.; Crovari, P.; Icardi, G.

In: Journal of Viral Hepatitis, Vol. 13, No. 1, 01.2006, p. 5-10.

Research output: Contribution to journalArticle

Ansaldi, F, Bruzzone, B, Testino, G, Bassetti, M, Gasparini, R, Crovari, P & Icardi, G 2006, 'Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection', Journal of Viral Hepatitis, vol. 13, no. 1, pp. 5-10. https://doi.org/10.1111/j.1365-2893.2005.00646.x
Ansaldi, F. ; Bruzzone, B. ; Testino, G. ; Bassetti, M. ; Gasparini, R. ; Crovari, P. ; Icardi, G. / Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection. In: Journal of Viral Hepatitis. 2006 ; Vol. 13, No. 1. pp. 5-10.
@article{e5c5c44e1d7147118c7b1555f2bdaa0b,
title = "Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection",
abstract = "Reduction of the window period of hepatitis C virus (HCV) infection represents an important goal in the transfusional and diagnostic setting. A prototype assay designed to simultaneously detect circulating HCV antigen and anti-HCV, has been developed. Aim of this study was to evaluate the performance of this new assay in terms of specificity and sensitivity and to compare its efficacy with commercial assays. To evaluate the specificity of the assay, 400 samples from the general population and 100 'difficult' sera, negative for anti-HCV, were tested. To assess sensitivity, the new test was used on 76 PCR-positive and anti-HCV negative sera, seven natural or commercial seroconversion panels that included 17 RNA-positive and anti-HCV negative sera and 31 anti-HCV positive sera, 20 weak anti-HCV positive sera, 80 viraemic and anti-HCV-positive sera from patients infected with different subtypes and 10 sera from patients with HBV-HCV or HIV-HCV co-infections. Of 500 anti-HCV negative samples, 499 (99.8{\%}) were negative with a cut-off index",
keywords = "Antigen, Diagnosis, HCV, Immunoassay, Window period",
author = "F. Ansaldi and B. Bruzzone and G. Testino and M. Bassetti and R. Gasparini and P. Crovari and G. Icardi",
year = "2006",
month = "1",
doi = "10.1111/j.1365-2893.2005.00646.x",
language = "English",
volume = "13",
pages = "5--10",
journal = "Journal of Viral Hepatitis",
issn = "1352-0504",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection

AU - Ansaldi, F.

AU - Bruzzone, B.

AU - Testino, G.

AU - Bassetti, M.

AU - Gasparini, R.

AU - Crovari, P.

AU - Icardi, G.

PY - 2006/1

Y1 - 2006/1

N2 - Reduction of the window period of hepatitis C virus (HCV) infection represents an important goal in the transfusional and diagnostic setting. A prototype assay designed to simultaneously detect circulating HCV antigen and anti-HCV, has been developed. Aim of this study was to evaluate the performance of this new assay in terms of specificity and sensitivity and to compare its efficacy with commercial assays. To evaluate the specificity of the assay, 400 samples from the general population and 100 'difficult' sera, negative for anti-HCV, were tested. To assess sensitivity, the new test was used on 76 PCR-positive and anti-HCV negative sera, seven natural or commercial seroconversion panels that included 17 RNA-positive and anti-HCV negative sera and 31 anti-HCV positive sera, 20 weak anti-HCV positive sera, 80 viraemic and anti-HCV-positive sera from patients infected with different subtypes and 10 sera from patients with HBV-HCV or HIV-HCV co-infections. Of 500 anti-HCV negative samples, 499 (99.8%) were negative with a cut-off index

AB - Reduction of the window period of hepatitis C virus (HCV) infection represents an important goal in the transfusional and diagnostic setting. A prototype assay designed to simultaneously detect circulating HCV antigen and anti-HCV, has been developed. Aim of this study was to evaluate the performance of this new assay in terms of specificity and sensitivity and to compare its efficacy with commercial assays. To evaluate the specificity of the assay, 400 samples from the general population and 100 'difficult' sera, negative for anti-HCV, were tested. To assess sensitivity, the new test was used on 76 PCR-positive and anti-HCV negative sera, seven natural or commercial seroconversion panels that included 17 RNA-positive and anti-HCV negative sera and 31 anti-HCV positive sera, 20 weak anti-HCV positive sera, 80 viraemic and anti-HCV-positive sera from patients infected with different subtypes and 10 sera from patients with HBV-HCV or HIV-HCV co-infections. Of 500 anti-HCV negative samples, 499 (99.8%) were negative with a cut-off index

KW - Antigen

KW - Diagnosis

KW - HCV

KW - Immunoassay

KW - Window period

UR - http://www.scopus.com/inward/record.url?scp=33644874357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644874357&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2893.2005.00646.x

DO - 10.1111/j.1365-2893.2005.00646.x

M3 - Article

C2 - 16364076

AN - SCOPUS:33644874357

VL - 13

SP - 5

EP - 10

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

SN - 1352-0504

IS - 1

ER -